Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionKingsview Wealth Management, LLC
Latest Disclosed Ownership15,711 shares
Latest Disclosed Value $ 2,189,636
Kingsview Wealth Management, LLC ownership in GILD / Gilead Sciences, Inc.

On May 12, 2026 - Kingsview Wealth Management, LLC filed a 13F-HR form disclosing ownership of 15,711 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,189,636 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 16,463 shares of Gilead Sciences, Inc.. This represents a change in shares of -4.57% during the quarter.

Kingsview Wealth Management, LLC has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GILEAD SCIENCES COM 375558103 15,711 -752 -4.57 2,190 8.37 0.0246
2026-02-09 2025-12-31 13F GILEAD SCIENCES COM 375558103 16,463 -50 -0.30 2,021 10.26 0.0291
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 16,513 -24,866 -60.09 1,833 -60.06 0.0280
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 41,379 -1,872 -4.33 4,588 -5.34 0.0777
2025-05-02 2025-03-31 13F GILEAD SCIENCES COM 375558103 43,251 1,237 2.94 4,846 24.90 0.0913
2025-01-28 2024-12-31 13F GILEAD SCIENCES COM 375558103 42,014 22,091 110.88 3,881 132.34 0.0756
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 19,923 1,628 8.90 1,670 33.07 0.0351
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 18,295 -27 -0.15 1,255 -6.48 0.0297
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 18,322 -406 -2.17 1,342 -11.54 0.0337
2024-02-08 2023-12-31 13F GILEAD SCIENCES COM 375558103 18,728 -1,841 -8.95 1,517 -1.56 0.0453
2023-11-07 2023-09-30 13F GILEAD SCIENCES COM 375558103 20,569 -18,612 -47.50 1,541 -48.96 0.0554
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 39,181 -7,481 -16.03 3,020 -22.01 0.1184
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 46,662 12,949 38.41 3,872 33.76 0.1625
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 33,713 11,587 52.37 2,894 112.01 0.1257
2022-11-15 2022-09-30 13F GILEAD SCIENCES COM 375558103 22,126 3,342 17.79 1,365 17.57 0.0647
2022-08-16 2022-06-30 13F GILEAD SCIENCES COM 375558103 18,784 -4,173 -18.18 1,161 -14.88 0.0555
2024-02-08 2022-03-31 13F GILEAD SCIENCES COM 375558103 22,957 4,978 27.69 1,365 4.52 0.0601
2022-02-17 2021-12-31 13F GILEAD SCIENCES COM 375558103 17,979 1,046 6.18 1,305 10.31 0.0543
2021-12-03 2021-09-30 13F GILEAD SCIENCES COM 375558103 16,933 1,014 6.37 1,183 7.55 0.0561
2021-08-17 2021-06-30 13F GILEAD SCIENCES COM 375558103 15,919 2,137 15.51 1,100 20.09 0.0543
2021-05-24 2021-03-31 13F GILEAD SCIENCES COM 375558103 13,782 695 5.31 916 20.21 0.0520
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 13,087 -3,468 -20.95 762 -27.15 0.0552
2020-11-19 2020-09-30 13F GILEAD SCIENCES COM 375558103 16,555 2,242 15.66 1,046 -5.00 0.0937
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 14,313 1,819 14.56 1,101 17.88 0.1102
2020-05-11 2020-03-31 13F GILEAD SCIENCES COM 375558103 12,494 8,444 208.49 934 255.13 0.1261
2020-01-31 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 4,050 4,050 -67.58 263 -71.84 0.0330
2020-01-29 2018-12-31 13F GILEAD SCIENCES COM 375558103 0 -2,635 -100.00 0 -100.00
2020-01-29 2018-09-30 13F GILEAD SCIENCES COM 375558103 2,635 2,635 203 0.0412
2020-01-29 2018-06-30 13F GILEAD SCIENCES COM 375558103 0 -3,423 -100.00 0 -100.00
2020-01-29 2018-03-31 13F GILEAD SCIENCES COM 375558103 3,423 3,423 258 0.0641
2020-01-29 2017-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,274 -100.00 0 -100.00
2020-01-29 2017-06-30 13F GILEAD SCIENCES COM 375558103 3,274 -1,681 -33.93 232 -31.16 0.1194
2020-01-29 2017-03-31 13F GILEAD SCIENCES COM 375558103 4,955 4,955 337 0.1999
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-12-03 2021-09-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-17 2021-06-30 13F GILEAD SCIENCES COM Call 2,000 3 n/a n/a n/a
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-11 2020-03-31 13F GILEAD SCIENCES COM Call 5,100 2,450.00 1 n/a n/a n/a
2020-01-31 2019-12-31 13F/A GILEAD SCIENCES COM Call 200 -96.08 0 -100.00 n/a n/a n/a
2020-01-29 2018-12-31 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-01-29 2018-09-30 13F GILEAD SCIENCES COM Call 800 1 n/a n/a n/a
2020-01-29 2018-06-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-01-29 2018-03-31 13F GILEAD SCIENCES COM Call 900 4 n/a n/a n/a
2020-01-29 2017-09-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-01-29 2017-06-30 13F GILEAD SCIENCES COM Call 1,300 333.33 3 200.00 n/a n/a n/a
2020-01-29 2017-03-31 13F GILEAD SCIENCES COM Call 300 1 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 n/a n/a n/a
2021-05-24 2021-03-31 13F GILEAD SCIENCES COM Put 100 0 n/a n/a n/a
2020-11-19 2020-09-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 n/a n/a n/a
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM Put 200 100.00 0 n/a n/a n/a
2020-05-11 2020-03-31 13F GILEAD SCIENCES COM Put 100 -50.00 0 n/a n/a n/a
2020-01-29 2017-06-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 n/a n/a n/a
2020-01-29 2017-03-31 13F GILEAD SCIENCES COM Put 500 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.